drugset / Trial / NCT03649945
Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label, randomized trial, it compares the efficacy and safety between apatinib combined chemotheray and chemotherapy for adjuvant treatment of esophageal cancer
Timeline
- Start
- 2018-11
- Primary completion
- 2020-11
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Docetaxel | Small molecule | 75 mg/m2 | — |
| Comparator | Endostar | Protein / enzyme biologic | 7.5 mg/m2 | — |
| Comparator | Nedaplatin | Small molecule | 80 mg/m2 | — |